NEIL3
Basic information
Region (hg38): 4:177309874-177362936
Links
Transcripts
Transcript IDs starting with ENST are treated as Ensembl, all others as RefSeq. Showing 4 of 6.
| Transcript ID | Protein ID | Coding exons | MANE Select | MANE Plus Clinical |
|---|---|---|---|---|
ENST00000264596.4 | ENSP00000264596.3 | 10 | yes | - |
ENST00000513321.1 | ENSP00000424735.1 | 2 | - | - |
ENST00000905043.1 | ENSP00000575102.1 | 10 | - | - |
ENST00000939669.1 | ENSP00000609728.1 | 5 | - | - |
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (64 variants)
- not_provided (5 variants)
- Low-frequency_sensorineural_hearing_impairment (1 variants)
- Low-frequency_hearing_loss (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NEIL3 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000018248.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 3 | 4 | |||
| missense | 66 | 5 | 71 | |||
| nonsense | 1 | 1 | ||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 1 | 1 | ||||
| Total | 0 | 0 | 69 | 8 | 0 |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| NEIL3 | protein_coding | protein_coding | ENST00000264596 | 10 | 53108 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 125675 | 0 | 73 | 125748 | 0.000290 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | -0.148 | 335 | 327 | 1.02 | 0.0000164 | 4000 |
| Missense in Polyphen | 97 | 100.82 | 0.96215 | 1239 | ||
| Synonymous | -0.219 | 118 | 115 | 1.03 | 0.00000566 | 1119 |
| Loss of Function | 1.26 | 17 | 23.6 | 0.721 | 0.00000107 | 332 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.00105 | 0.00104 |
| Ashkenazi Jewish | 0.000302 | 0.000298 |
| East Asian | 0.000109 | 0.000109 |
| Finnish | 0.00 | 0.00 |
| European (Non-Finnish) | 0.000310 | 0.000308 |
| Middle Eastern | 0.000109 | 0.000109 |
| South Asian | 0.000441 | 0.000425 |
| Other | 0.000164 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: DNA glycosylase which prefers single-stranded DNA (ssDNA), or partially ssDNA structures such as bubble and fork structures, to double-stranded DNA (dsDNA). In vitro, displays strong glycosylase activity towards the hydantoin lesions spiroiminodihydantoin (Sp) and guanidinohydantoin (Gh) in both ssDNA and dsDNA; also recognizes FapyA, FapyG, 5-OHU, 5-OHC, 5- OHMH, Tg and 8-oxoA lesions in ssDNA. No activity on 8-oxoG detected. Also shows weak DNA-(apurinic or apyrimidinic site) lyase activity. In vivo, appears to be the primary enzyme involved in removing Sp and Gh from ssDNA in neonatal tissues. Seems to be an important facilitator of cell proliferation in certain populations, for example neural stem/progenitor cells and tumor cells, suggesting a role in replication-associated DNA repair. {ECO:0000269|PubMed:12433996, ECO:0000269|PubMed:19170771, ECO:0000269|PubMed:22569481, ECO:0000269|PubMed:23755964}.;
- Pathway
- Base excision repair - Homo sapiens (human)
(Consensus)
Recessive Scores
- pRec
- 0.0759
Intolerance Scores
- loftool
- 0.974
- rvis_EVS
- 2.16
- rvis_percentile_EVS
- 98.01
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0105
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- base-excision repair;nucleotide-excision repair
- Cellular component
- nucleus;nucleoplasm
- Molecular function
- bubble DNA binding;damaged DNA binding;double-stranded DNA binding;single-stranded DNA binding;DNA-(apurinic or apyrimidinic site) endonuclease activity;zinc ion binding;DNA N-glycosylase activity;class I DNA-(apurinic or apyrimidinic site) endonuclease activity